Scarica l'app Stockscreener
1.34
4.69%
0.06
Dopo l'orario di chiusura:
1.38
0.04
+2.99%
Precedente Chiudi:
$1.28
Aprire:
$1.29
Volume 24 ore:
133.10K
Relative Volume:
0.07
Capitalizzazione di mercato:
$15.08M
Reddito:
$5.64M
Utile/perdita netta:
$-23.88M
Rapporto P/E:
-2.5283
EPS:
-0.53
Flusso di cassa netto:
$-22.36M
1 W Prestazione:
-4.29%
1M Prestazione:
+22.94%
6M Prestazione:
-28.34%
1 anno Prestazione:
-79.21%
Intervallo 1D:
$1.26
$1.44
Intervallo di 1 settimana:
$1.26
$1.44
Portata 52W:
$0.95
$7.19
Evogene Ltd Stock (EVGN) Company Profile
Confronta EVGN con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
EVGN
Evogene Ltd
|
1.34 | 15.08M | 5.64M | -23.88M | -22.36M | -0.53 |
|
VRTX
Vertex Pharmaceuticals Inc
|
452.16 | 115.95B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
534.91 | 56.52B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
322.06 | 39.44B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ARGX
Argen X Se Adr
|
542.47 | 35.14B | 2.58B | 1.06B | -1.28B | 16.33 |
|
ONC
Beone Medicines Ltd Adr
|
245.16 | 28.51B | 3.81B | -644.79M | -669.77M | -6.24 |
Evogene Ltd Stock (EVGN) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2021-10-08 | Iniziato | ROTH Capital | Buy |
| 2021-07-29 | Iniziato | Aegis Capital | Buy |
| 2020-12-01 | Iniziato | Cantor Fitzgerald | Overweight |
| 2013-12-16 | Iniziato | Oppenheimer | Outperform |
Evogene Ltd Borsa (EVGN) Ultime notizie
Evogene Announces Annual General Meeting for August 2025 - TipRanks
Citadel Advisors LLC Makes New Investment in Evogene Ltd. (NASDAQ:EVGN) - Defense World
Evogene Becomes Talk Of Retail Town As Stock Doubles On GenAI Drug, Agri Discovery Model With Google Cloud - MSN
Cannabis Stocks To Keep An Eye On – June 10th - Defense World
Evogene, Google Cloud innovation to revolutionise ag-chemicals - Far Eastern Agriculture
Evogene Becomes Talk Of Retail Town As Stock Doubles On Genai Drug, Agri Discovery Model With Google Cloud - MENAFN.com
AI And Tech Stocks Climb With Major Partnerships And Innovations - Finimize
Evogene iyo Google Cloud Unveil Model ee Naqshadaynta Molecule Generative, Hormoodka Waa Cusub ee Sayniska Nolosha AI - Unite.AI
AI Innovations Propel Industry Players To New Heights - Finimize
Evogene and Google Cloud Unveil Foundation Model for Generative Molecule Design, Pioneering a New Era in Life-Science AI - Unite.AI
Top Midday Gainers - MarketScreener
Evogene (EVGN) Stock Nearly Doubles in a Single Day with Explosive 89% Surge - Daily Chhattisgarh News
Evogene’s AI Breakthrough Ignites Stock Surge: What’s Driving the Hype? - RagingBull
Pre-market Movers: EVGN, WINT, CARM, UNCY... - RTTNews
Jane Street Group LLC Acquires Shares of 21,345 Evogene Ltd. (NASDAQ:EVGN) - Defense World
Evogene announces completion of generative AI foundation model with Google Cloud - TipRanks
Evogene Announces Completion of First-In-Class Foundation Model for Generative Molecule Design, Developed in Collaboration with Google Cloud - PR Newswire
EVGNEvogene Reports First Quarter 2025 Financial Results - mx.advfn.com
Evogene Announces the Appointment of Nir Nimrodi as the New Chairperson of the Board, Effective March 5, 2025 - mx.advfn.com
Evogene price target lowered to $3.50 from $6 at Alliance Global Partners - TipRanks
Evogene Announces Leadership Change and Strategic Shift at Biomica - TipRanks
Evogene (TSE:EVGN) Given a C$1.00 Price Target by Royal Bank of Canada Analysts - Defense World
Evogene's ChemPass AI Tech-Engine is Introduced with New Breakthrough Machine Learning Technology for Target-Protein Discovery - Barchart.com
Evogene Ltd. Earnings Call: Balancing Growth and Challenges - TipRanks
Evogene Ltd (EVGN) Q1 2025 Earnings Call Highlights: Strategic Expense Reductions and Promising ... - Yahoo Finance
Evogene stock target cut to $3.50, maintains buy at Lake Street - Investing.com Nigeria
Evogene price target lowered to $3.50 from $5 at Lake Street - TipRanks
Evogene Ltd. (NASDAQ:EVGN) Q1 2025 Earnings Call Transcript - Insider Monkey
Evogene: Q1 Earnings Snapshot - New Haven Register
Evogene Reports First Quarter 2025 Financial Results - Krishak Jagat
Evogene Ltd. Reports Q1 2025 Financial Results - TipRanks
Evogene earnings beat by $0.35, revenue fell short of estimates - Investing.com Australia
Evogene Q1 2025 Earnings Call Transcript - MarketBeat
Earnings call transcript: Evogene Reports Narrower Loss in Q1 2025 - Investing.com
Earnings call transcript: Evogene Reports Narrower Loss in Q1 2025 By Investing.com - Investing.com UK
Evogene Announces Q1 2025 Financial Results and Strategic Acquisition - TipRanks
Evogene (NASDAQ:EVGN) Earns Sell Rating from Analysts at StockNews.com - Defense World
StockNews.com Begins Coverage on Evogene (NASDAQ:EVGN) - Defense World
Evogene (EVGN) Projected to Post Quarterly Earnings on Wednesday - Defense World
Evogene Schedules First Quarter 2025 Financial Results Release - Krishak Jagat
Casterra Announces Additional $2.2 Million of Purchase Orders to Supply Castor Seeds for New African Territories - Barchart.com
Evogene Announces Pricing Of US$8,500,000 Registered Direct Offering - Barchart.com
Evogene (NASDAQ:EVGN) Coverage Initiated by Analysts at StockNews.com - Defense World
Evogene (NASDAQ:EVGN) Now Covered by Analysts at StockNews.com - Defense World
Evogene Ltd Azioni (EVGN) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.39%
0.42%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):